Payment overview · 2025
General Payments
$230.30
7 reported records · 3 companies
Healthcare provider profile · identity verified
Daniel Edwin Benyo, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SUGARLOAF, PA · NPI 1023438777
Verified facts
What the public records show
CMS Open Payments records show Daniel Edwin Benyo, M.D. received $230.30 in general payments during 2025 across 7 reported records.
Novo Nordisk Inc accounted for 54.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 98 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $124.71 | 54.1% | 1 | 2025 |
| Viatris Specialty LLC | Unresolved — no canonical attribution shown | $91.04 | 39.5% | 5 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $14.55 | 6.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $230.30 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $124.71 | 1 | 2025 |
Source payment records
|
|||||
| YUPELRI Normalized: yupelri |
Drug | Viatris Specialty LLC | $91.04 | 5 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $14.55 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 98 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
98 | 21 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1583 | 225 |
| Levothyroxine Sodium | Levothyroxine Sodium | 965 | 128 |
| Lisinopril | Lisinopril | 842 | 121 |
| Metoprolol Tartrate | Metoprolol Tartrate | 763 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 726 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 697 | 117 |
| Eliquis | Apixaban | 680 | 57 |
| Furosemide | Furosemide | 634 | 79 |
| Gabapentin | Gabapentin | 634 | 79 |
| Sertraline Hcl | Sertraline Hcl | 516 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 507 | 87 |
| Losartan Potassium | Losartan Potassium | 455 | 82 |
| Omeprazole | Omeprazole | 446 | 84 |
| Tamsulosin Hcl | Tamsulosin Hcl | 424 | 54 |
| Buspirone Hcl | Buspirone Hcl | 375 | 34 |
| Potassium Chloride | Potassium Chloride | 369 | 38 |
| Famotidine | Famotidine | 340 | 70 |
| Simvastatin | Simvastatin | 332 | 57 |
| Carvedilol | Carvedilol | 326 | 35 |
| Mirtazapine | Mirtazapine | 308 | 23 |
| Metformin Hcl | Metformin Hcl | 303 | 68 |
| Jardiance | Empagliflozin | 285 | 35 |
| Quetiapine Fumarate | Quetiapine Fumarate | 254 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 241 | 56 |
| Trazodone Hcl | Trazodone Hcl | 238 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 234 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 233 | 28 |
| Alprazolam | Alprazolam | 232 | 45 |
| Donepezil Hcl | Donepezil Hcl | 232 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 232 | 33 |
| Levetiracetam | Levetiracetam | 208 | suppressed |
| Lorazepam | Lorazepam | 203 | 40 |
| Torsemide | Torsemide | 203 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 200 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 187 | 23 |
| Tramadol Hcl | Tramadol Hcl | 186 | 40 |
| Allopurinol | Allopurinol | 173 | 25 |
| Prednisone | Prednisone | 163 | 75 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 161 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 151 | 54 |
| Memantine Hcl | Memantine Hcl | 141 | suppressed |
| Risperidone | Risperidone | 139 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 137 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 133 | 47 |
| Citalopram Hbr | Citalopram Hydrobromide | 131 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 129 | 19 |
| Spironolactone | Spironolactone | 126 | 15 |
| Xarelto | Rivaroxaban | 123 | 14 |
| Synthroid | Levothyroxine Sodium | 122 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 120 | suppressed |
| Metolazone | Metolazone | 115 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 114 | 19 |
| Tradjenta | Linagliptin | 112 | suppressed |
| Finasteride | Finasteride | 110 | 19 |
| Meloxicam | Meloxicam | 109 | 18 |
| Midodrine Hcl | Midodrine Hcl | 109 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 108 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 107 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 99 | 85 |
| Ozempic | Semaglutide | 98 | 21 |
| Valsartan | Valsartan | 98 | 25 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 97 | suppressed |
| Lactulose | Lactulose | 94 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 93 | suppressed |
| Ezetimibe | Ezetimibe | 93 | 17 |
| Myrbetriq | Mirabegron | 91 | suppressed |
| Carbamazepine Er | Carbamazepine | 90 | suppressed |
| Trulicity | Dulaglutide | 90 | 17 |
| Clonazepam | Clonazepam | 88 | 15 |
| Cefdinir | Cefdinir | 87 | 65 |
| Mounjaro | Tirzepatide | 83 | 18 |
| Digoxin | Digoxin | 77 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 75 | 50 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 73 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 73 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 72 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 71 | suppressed |
| Atenolol | Atenolol | 68 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 67 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 67 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 66 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 66 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 65 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 64 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 63 | suppressed |
| Azithromycin | Azithromycin | 62 | 50 |
| Calcitriol | Calcitriol | 56 | suppressed |
| Glimepiride | Glimepiride | 56 | suppressed |
| Pregabalin | Pregabalin | 56 | 11 |
| Alendronate Sodium | Alendronate Sodium | 55 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 55 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 55 | 12 |
| Sucralfate | Sucralfate | 55 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 52 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 52 | suppressed |
| Phenytoin | Phenytoin | 52 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 51 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 50 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 50 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | suppressed |
| Methocarbamol | Methocarbamol | 47 | 21 |
| Latanoprost | Latanoprost | 46 | suppressed |
| Olanzapine | Olanzapine | 44 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 44 | 15 |
| Spiriva Respimat | Tiotropium Bromide | 43 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 42 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 21 |
| Januvia | Sitagliptin Phosphate | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 16 |
| Methotrexate | Methotrexate Sodium | 39 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 38 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 38 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 38 | 11 |
| Mupirocin | Mupirocin | 37 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 35 | suppressed |
| Nystatin | Nystatin | 35 | 14 |
| Fenofibrate | Fenofibrate | 34 | suppressed |
| Glipizide Er | Glipizide | 34 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 33 | 12 |
| Amoxicillin | Amoxicillin | 32 | 17 |
| Aripiprazole | Aripiprazole | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 30 | 12 |
| Methimazole | Methimazole | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 27 | suppressed |
| Repatha Sureclick | Evolocumab | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 11 |
| Carbamazepine | Carbamazepine | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 17 |
| Levemir Flexpen | Insulin Detemir | 25 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 25 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 24 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 11 |
| Entresto | Sacubitril/Valsartan | 24 | suppressed |
| Colchicine | Colchicine | 23 | suppressed |
| Jantoven | Warfarin Sodium | 23 | suppressed |
| Letrozole | Letrozole | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 20 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Glucagon Emergency Kit | Glucagon | 19 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 18 | suppressed |
| Azathioprine | Azathioprine | 18 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Lumigan | Bimatoprost | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Desloratadine | Desloratadine | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Phenobarbital | Phenobarbital | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Brinzolamide | Brinzolamide | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 12 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Cefadroxil | Cefadroxil | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | 11 |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Paliperidone Er | Paliperidone | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $230.30 · 7 records | Novo Nordisk Inc | Ozempic, REXULTI, YUPELRI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error